-
Reviewer Acknowledgements for Cancer and Clinical Oncology, Vol. 8, No. 1
-
Skin health in oncology: evidence-based skin care for cancer patients
-
Optimal management of venous thromboembolism in adolescent and young adult oncology patients
-
Still human: Presence, oncology, and artificial intelligence
-
Implementing oncology clinical trials in Nigeria: A model for Capacity building.
-
Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic Experts
-
Implementing UK Oncology Nursing Society–Informed Digital Symptom Triage With Episode-Based Review in Routine NHS Acute Oncology: Service Evaluation
-
Clinical trial enrollment of adolescent and young adult patients with cancer: a systematic review of the literature and proposed solutions
-
Changes in Distress Screening and Information Reception Among Cancer Patients Following a Training for Oncology Nursing Staff: A Pilot Study
-
Impact of Multimodal Oncological Therapy on Survival and Local Control in Unresectable Perihilar Cholangiocarcinoma
-
Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology
-
Multimodal management of hormonal and oncological progression in PTHrP-secreting pancreatic neuroendocrine tumours
-
Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC): An Aggressive Disease Course and Limitations for Personalized Oncology
-
Internet of Things–Enhanced Mathematical Oncology: Conceptual Framework for Adaptive Cancer Care Modeling
-
Cardiovascular Symptom Tracking Among Patients With Cancer in Cardio-Oncology Care: Qualitative Study Using the Capability, Opportunity, Motivation–Behavior (COM-B) Framework
-
Enhancing Oncological Care for India's Aging Population: Addressing the Complex Needs of Older Adults With Cancer
-
AI-Enhanced Predictive Analytics to Optimize Tele-Oncology Implementation in Rural Settings: Scoping Review
-
Perioperative Treatment Patterns for Muscle-Invasive Bladder Cancer Patients Undergoing Radical Cystectomy in the Adjuvant Immunotherapy Era: A Retrospective Analysis of US Community Oncology Practice
-
Shifting a paradigm: highlights of model informed drug development in dosage selection and optimization for oncology products
-
Patient, care partner, and oncologist perspectives on clinically important survival thresholds after considering time toxicity in advanced cancer
-
Advances in Phase III Clinical Trials and Future Challenges of Targeted Therapy in Advanced Ovarian Cancer
-
Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease
-
Publisher Correction: Perioperative Treatment Patterns for Muscle-Invasive Bladder Cancer Patients Undergoing Radical Cystectomy in the Adjuvant Immunotherapy Era: A Retrospective Analysis of US Community Oncology Practice
-
Retrospective Analysis of HER2 Testing, Treatment Patterns, and Clinical Outcomes in Patients With Locally Advanced or Metastatic NSCLC With HER2 Mutations in France
